Preliminary STRATAS data support aggressive rotablation
This article was originally published in Clinica
Aggressive Rotablator atherectomy safely improves acute gain, according to early data from the first STRATAS patients presented at the American Heart Association meeting in Anaheim (November 13th-16th). So far 32 pilot angiograms have been evaluated (see table), but eventually 500 patients will be included in the 15 site prospective randomised trial of routine versus aggressive burr use, said Dr Patrick Whitlow of the Cleveland Clinic Foundation, Ohio.
You may also be interested in...
Turku, Finland-based Forendo Pharma has entered into a license and collaboration deal with Novartis involving the identification of novel drugs to treat chronic liver diseases.
Three accelerated assessment requests will either be granted or rejected this week at the European Medicines Agency.
A new work sharing pilot has been launched to evaluate jointly generic drugs intended for launch in Singapore and Malaysia.